- Ticker
- ADIL
- Price
- 1.13
- Stock movement down
- -0.03 (-2.59%)
- Company name
- Adial Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.29M
- Ent value
- -2.13M
- Price/Sales
- -
- Price/Book
- 0.24
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 71.39%
- 1 year return
- -85.78%
- 3 year return
- -73.79%
- 5 year return
- -57.01%
- 10 year return
- -
Last updated: 2024-04-08
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ADIL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.24 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.14M |
| EPS (TTM) | -15.25 |
| FCF per share (TTM) | -11.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -16.06M |
| Net income (TTM) | -15.70M |
| EPS (TTM) | -15.25 |
| EPS (1y forward) | -15.50 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.75M |
| Net receivables | 0.00 |
| Total current assets | 6.77M |
| Goodwill | 248.97K |
| Intangible assets | 4.62K |
| Property, plant and equipment | 0.00 |
| Total assets | 7.74M |
| Accounts payable | 278.20K |
| Short/Current long term debt | 220.25K |
| Total current liabilities | 1.33M |
| Total liabilities | 2.33M |
| Shareholder's equity | 5.41M |
| Net tangible assets | 4.70M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -11.81M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -11.81M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -290.17% |
| Return on Assets | -202.74% |
| Return on Invested Capital | -287.25% |
| Cash Return on Invested Capital | -216.11% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.14 |
| Daily high | 1.17 |
| Daily low | 1.05 |
| Daily Volume | 1.06M |
| All-time high | 208.25 |
| 1y analyst estimate | 187.50 |
| Beta | 0.98 |
| EPS (TTM) | -15.25 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 10 May 2024 |
Downside potential
Loading...
Downside potential data
| ADIL | S&P500 | |
| Current price drop from All-time high | -99.46% | -0.85% |
| Highest price drop | -99.61% | -56.47% |
| Date of highest drop | 26 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -77.04% | -11.35% |
| Avg time to new high | 130 days | 13 days |
| Max time to new high | 1316 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.29M
Marketcap category
Small-cap
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Employees
16
Website
Investor relations
-
SEC filings
CEO
William B. Stilley
Country
USA
City
Charlottesville
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page